Market Place
Sourcing Support
CODA Biotherapeutics Announces New Preclinical Data From Epilepsy Program
01 Jun 2022 //
PRNEWSWIRE
CODA BioTx Names Susan Catalano, Ph.D., as Chief Scientific Officer
08 Mar 2022 //
PRNEWSWIRE
CODA`s Chemogenetic Gene Therapy Platform Can Control Focal Seizures in vivo
07 Dec 2021 //
PRNEWSWIRE
CODA Biotherapeutics Receives Grant from the NINDS,NIH
10 Nov 2020 //
PRNEWSWIRE
CODA Biotherapeutics Announces Research Collaboration With The Facial Pain
20 May 2020 //
PRNEWSWIRE
CODA Biotherapeutics Acquires Attenua and Three Clinical Stage Assets
05 Feb 2020 //
PR NEWSWIRE
CODA Biotherapeutics Deepens Gene Therapy Expertise with Industry Veteran
23 Nov 2019 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.